SCHEMBL2046038

SCHEMBL2046038

C[Si](C)=[Ti](Cl)(Cl)(NC(=O)c1ccccc1)C1c2ccccc2-c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSP90AA1 P07900 2/20 0.38
HSP90AB1 P08238 2/20 0.38
KDM4E B2RXH2 1/20 0.38
APAF1 O14727 1/20 0.38
TDP2 O95551 1/20 0.38
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
CASP3 P42574 1/20 0.38
HTT P42858 1/20 0.38
GALK1 P51570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035134 0.86 MEN1 (0.37) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL2036835 0.79 MEN1 (0.41) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL2033418 0.78 MEN1 (0.40) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL2036882 0.69 HPGD (0.40) LMNAALDH1A1HSP90AA1HSP90AB1HPGD
Hydrochloric Acid SCHEMBL2046037 0.67 KMT2A (0.42) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL6905916 0.66 MAPT (0.34) KMT2AMEN1LMNAALDH1A1MAPT
SCHEMBL30735994 0.66 KMT2A (0.75) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL29124181 0.66 KMT2A (0.75) KMT2AMEN1LMNAGAAALDH1A1
SCHEMBL2050883 0.64 MEN1 (0.30) KMT2AMEN1POLB
SCHEMBL10556752 0.63 MAPT (0.64) ALDH1A1MAPTPOLBHTTHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701595-B2 Process for producing novel synthetic basestocks EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-07-11 US disclosed
EP-2516598-B1 PROCESS FOR PRODUCING NOVEL SYNTHETIC BASESTOCKS EXXONMOBIL CHEM PATENTS INC (US) 2016-06-29 EP disclosed
US-8530712-B2 Process for producing novel synthetic basestocks EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-10 US disclosed
US-20130131410-A1 Process for Producing Novel Synthetic Basestocks EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-05-23 US disclosed
EP-2516598-A2 PROCESS FOR PRODUCING NOVEL SYNTHETIC BASESTOCKS Exxonmobil Chemical Patents Inc. (US) 2012-10-31 EP disclosed
WO-2011079042-A2 PROCESS FOR PRODUCING NOVEL SYNTHETIC BASESTOCKS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-06-30 WO disclosed
US-20110160502-A1 Process for Producing Novel Synthetic Basestocks EXXONMOBIL CHEMICAL PATENTS INC. 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131410-A1 Process for Producing Novel Synthetic Basestocks PYM1, SCO2, SPIN4 KMT2A 3597/4885MEN1 2463/4885LMNA 1165/4885
US-20110160502-A1 Process for Producing Novel Synthetic Basestocks PYM1, SPIN4, SCO2 KMT2A 4148/4885MEN1 2848/4885LMNA 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.